Examiner: FOWLER, ALAN JEROME

Tech Center 1700 • Art Units: 1691 1759

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-65.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

§101 Eligibility

§102 Novelty

100.0%

§103 Obviousness

§112 Clarity

App #	Title	Status	Assignee
18467698	NEDDYLATION INHIBITION FOR USE IN THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION	Non-Final OA	Northwestern University
18567075	SKIN CARE COMPOSITION	Non-Final OA	Conopco, Inc., d/b/a UNILEVER
18482835	NOSE-TO-BRAIN DELIVERY FORMULATION OF NIMODIPINE, PREPARATION AND USE	Non-Final OA	Nasal-Phyto (Shanghai) Pharmaceutical Technology Co., Ltd.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.